Showing results (271-280 of 568) with videos related to
Sort By:
Pageof 57
Peptides|October 20, 2009
Evolution and functional divergence of enzymes involved in sesquiterpenoid hormone biosynthesis in crustaceans and insectsJerome H L Hui, Alexander Hayward, William G Bendena, et al.Journal of the American Geriatrics Society|October 1, 1996
The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black AmericansH C Hendrie, S Gao, K S Hall, et al.Social Science & Medicine (1982)|January 1, 1985
The impact of reading on physicians' nonadherence to recommended standards of medical careS J Cohen, M Weinberger, S L Hui, et al.Journal of the American Geriatrics Society|June 23, 2015
Risk of Injury in Older Adults Using Gastrointestinal Antispasmodic and Anticholinergic MedicationsMichele M Spence, Fatima A Karim, Eric A Lee, et al.Pharmacy (Basel, Switzerland)|April 30, 2021
Medicines as Common Commodities or Powerful Potions? What Makes Medicines Reusable in People's EyesMonica Chauhan, Hamza Alhamad, Rachel McCrindle, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1993
Validation of probabilistic predictionsM E Miller, C D Langefeld, W M Tierney, et al.The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrationsErik A Imel, Linda A DiMeglio, Siu L Hui, et al.Protein Science : a Publication of the Protein Society|June 19, 2002
Correlation of protein functional properties in the crystal and in solution: the case study of T-state hemoglobinRobert W Noble, Laura D Kwiatkowski, Hilda L Hui, et al.Kidney International|August 1, 2000
Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptorS Tokizawa, N Shimizu, L Hui-Yu, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 8, 2020
Correction to: Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort StudyStephanie L Ho, Fang Niu, Suresh Pola, et al.Pageof 57